AR102135A1 - MONKEY OR DISABLED INDOLES AS INHIBITORS OF THE DENGUE VIRUS REPLICATION - Google Patents

MONKEY OR DISABLED INDOLES AS INHIBITORS OF THE DENGUE VIRUS REPLICATION

Info

Publication number
AR102135A1
AR102135A1 ARP150103152A ARP150103152A AR102135A1 AR 102135 A1 AR102135 A1 AR 102135A1 AR P150103152 A ARP150103152 A AR P150103152A AR P150103152 A ARP150103152 A AR P150103152A AR 102135 A1 AR102135 A1 AR 102135A1
Authority
AR
Argentina
Prior art keywords
dengue virus
compounds
indoles
monkey
disabled
Prior art date
Application number
ARP150103152A
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceuticals Inc
Univ Leuven Kath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc, Univ Leuven Kath filed Critical Janssen Pharmaceuticals Inc
Publication of AR102135A1 publication Critical patent/AR102135A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

La presente se refiere a compuestos de indol mono o disustituidos, métodos para prevenir o tratar infecciones por el virus del dengue mediante el uso de dichos compuestos y al uso de dichos compuestos como medicamento, más preferiblemente a su uso como un medicamento para tratar o prevenir infecciones por el virus del dengue. La presente se refiere además a composiciones farmacéuticas o preparaciones a partir de combinación de compuestos y a composiciones o preparados para uso como medicamento, más preferiblemente para la prevención o tratamiento de infecciones por el virus del dengue. También se refiere a los procesos de preparación de los compuestos. Reivindicación 1: Un compuesto de fórmula (1), una forma estereoisomérica, una sal, un solvato o un polimorfo farmacéuticamente aceptables de este, que comprende un grupo indol mono o disustituido; dicho compuesto se selecciona de un grupo donde R¹ es H, R² es F y R³ es H, F o CH₃; R¹ es F o CH₃, R² es OCH₃ y R³ es H; R¹ es H, R² es Cl y R³ es H o CH₃; R¹ es F, R² es H y R³ es CH₃; R¹ es H, R² es OCH₃ y R³ es Cl; R¹ es F, R² es F y R³ es H; R¹ es H, R² es OCH₃ y R³ es CH₃; o R¹ es CH₃, R² es H y R³ es F.This refers to mono or disubstituted indole compounds, methods for preventing or treating dengue virus infections through the use of said compounds and the use of said compounds as a medicament, more preferably for use as a medicament for treating or preventing Dengue virus infections. This also relates to pharmaceutical compositions or preparations from a combination of compounds and compositions or preparations for use as a medicine, more preferably for the prevention or treatment of dengue virus infections. It also refers to the processes of preparation of the compounds. Claim 1: A compound of formula (1), a stereoisomeric form, a pharmaceutically acceptable salt, solvate or polymorph thereof, comprising a mono or disubstituted indole group; said compound is selected from a group where R¹ is H, R² is F and R³ is H, F or CH₃; R¹ is F or CH₃, R² is OCH₃ and R³ is H; R¹ is H, R² is Cl and R³ is H or CH₃; R¹ is F, R² is H and R³ is CH₃; R¹ is H, R² is OCH₃ and R³ is Cl; R¹ is F, R² is F and R³ is H; R¹ is H, R² is OCH₃ and R³ is CH₃; or R¹ is CH₃, R² is H and R³ is F.

ARP150103152A 2014-10-01 2015-09-30 MONKEY OR DISABLED INDOLES AS INHIBITORS OF THE DENGUE VIRUS REPLICATION AR102135A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14187373 2014-10-01

Publications (1)

Publication Number Publication Date
AR102135A1 true AR102135A1 (en) 2017-02-08

Family

ID=51743264

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150103152A AR102135A1 (en) 2014-10-01 2015-09-30 MONKEY OR DISABLED INDOLES AS INHIBITORS OF THE DENGUE VIRUS REPLICATION

Country Status (1)

Country Link
AR (1) AR102135A1 (en)

Similar Documents

Publication Publication Date Title
AR108046A1 (en) INDOLINA DERIVATIVES REPLACED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE
ECSP22023220A (en) MONO OR DISUBSTITUTED INDOL DERIVATIVES AS INHIBITORS OF DENGUE VIRAL REPLICATION
CL2017000782A1 (en) Mono- or disubstituted indole derivatives as inhibitors of dengue virus replication
CL2017000742A1 (en) Mono or disubstituted Indoles as inhibitors of dengue virus replication
ECSP18073245A (en) INHIBITORS OF INHIBITORS OF INHIBITORS OF VIRAL REPLICATION OF DENGUE
AR111314A1 (en) INDOLINA DERIVATIVES REPLACED AS INHIBITORS OF THE DENGUE VIRIC REPLICATION
CL2017001822A1 (en) Mono or disubstituted indole derivatives as inhibitors of dengue virus replication
CL2018002784A1 (en) Derivatives of substituted indole compounds as inhibitors of dengue viral replication.
CO2018008421A2 (en) Indoline derivatives substituted as inhibitors of dengue viral replication
CO2018003369A2 (en) Indole mono- or disubstituted derivatives as inhibitors of dengue viral replication
CO2018003471A2 (en) Indole mono- or disubstituted derivatives as inhibitors of dengue viral replication
CR20190447A (en) Substituted indoline derivatives as dengue viral replication inhibitors
DOP2016000254A (en) PHARMECEUTIC FORMULATIONS OF PAN-RAF QUINASE INHIBITOR, PROCEDURES FOR THEIR PREPARATION, AND METHODS OF USE.
UY36124A (en) CARBOXAMIDE DERIVATIVES
UY36123A (en) CARBOXAMIDE DERIVATIVES
AR120158A2 (en) SUBSTITUTED INDOL MONO OR DI DERIVATIVES AS INHIBITORS OF DENGUE VIRAL REPLICATION
AR102135A1 (en) MONKEY OR DISABLED INDOLES AS INHIBITORS OF THE DENGUE VIRUS REPLICATION
AR106029A1 (en) DERIVATIVES OF INDOL MONO- OR DISABLED AS INHIBITORS OF THE VIRAL REPLICATION OF DENGUE
AR102136A1 (en) DERIVATIVES OF INDOL MONO- OR DISABLED AS INHIBITORS OF THE REPLICATION OF THE DENGUE VIRUS
CU20160170A7 (en) CARBOXAMIDE DERIVATIVES
AR105921A1 (en) THERAPEUTIC COMPOUNDS FOR PAIN AND SYNTHESIS OF THESE

Legal Events

Date Code Title Description
FB Suspension of granting procedure